General
Preferred name
ENFUVIRTIDE
Synonyms
Enfuvirtide acetate ()
Fuzeon ()
T20 ()
DP178 ()
DP-178 ()
T-20 ()
Pentafuside (trivial name) ()
Fuzeon T-20 ()
P&D ID
PD071713
CAS
914454-00-5
159519-65-0
Tags
available
drug
Approved by
FDA
EMA
First approval
2003
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
8
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugCentral
DrugCentral Approved Drugs
Natural product-based probes and drugs
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
14
Properties
(calculated by RDKit )
Molecular Weight
4489.19
Hydrogen Bond Acceptors
60
Hydrogen Bond Donors
63
Rotatable Bonds
151
Ring Count
9
Aromatic Ring Count
9
cLogP
-15.38
TPSA
1902.89
Fraction CSP3
0.56
Chiral centers
39.0
Largest ring
6.0
QED
0.02
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Microbiology&virology
Proteases/Proteasome
Target
HIV
Biosynthetic Origin
Peptide (Ribosomal)
Therapeutic Indication
Antiviral
Source data
